Oncology & Cancer

How cancer cells engineer macrophages to support cancer growth

A Ludwig Cancer Research study has identified a means by which cancer cells engineer the conversion of immune cells known as macrophages from destroyers of tumors to supporters of their growth and survival. The new research, ...

Oncology & Cancer

Cascade-responsive nanobomb for anti-tumor synergistic therapies

Reactive oxygen species (ROS) can act as signal carriers during the evolution of malignant tumors. At the appropriate concentration, ROS mediate signal transduction and cell growth. However, ROS are a double-edged sword, ...

Oncology & Cancer

High immunoscores may help some win the battle against cancer

Cancerous tumors are made up of many more components than just malignant cells from the tissue of origin. Immune cells can be recruited to the tumor site and form what is known as the tumor microenvironment. A subset of these ...

Oncology & Cancer

Tissue-engineered prostate tumours shed light on cancer spread

The international team led by Dr. Jacqui McGovern, from the Centre for Biomedical Technologies, used tissue engineering and regenerative medicine principles to create primary tumors with their microenvironment and humanized ...

Oncology & Cancer

New immunotherapy method targets tumor tissue only

Immunotherapy drugs are promising new weapons in the fight against cancer, but they are so strong that they can be toxic to the rest of the human body. The basic idea behind immunotherapy drugs is simple. Doctors inject special ...

page 22 from 40